Viewing Study NCT05149768

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:26 PM
Ignite Modification Date: 2026-01-28 @ 5:46 PM
Study NCT ID: NCT05149768
Status: RECRUITING
Last Update Posted: 2024-11-18
First Post: 2021-11-24
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Open Label Extension Study of Brentuximab Vedotin in Early dcSSc
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diffuse Cutaneous Systemic Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None systemic sclerosis View
None scleroderma View
None brentuximab vedotin View
None CD30-directed antibody-drug conjugate View
None antirheumatic agents View
None antineoplastic agents View
None skin diseases View
None immunologic factors View